Women's Health Diagnostics Market Size 2022 | Growth Outlook, Industry Report 2027

The latest research study “Women's Health Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global women's health diagnostics market size reached US$ 21.62 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 35.7 Billion by 2027, exhibiting at a CAGR of 8.10% during 2022-2027.

Women’s health diagnostics focus on treating and identifying various psychosocial, physical, and biological conditions of female patients. For instance, they help detect ovarian and breast cancer, gynecology disorder, hormone therapy, sexual health, osteoporosis, sexually transmitted infections (STIs), menopause, and benign conditions affecting the female body function. They include a series of laboratory tests, tools, and procedures, including ultrasound, chemotherapy, magnetic resonance imaging (MRI), image-guided breast biopsy, cordocentesis, or umbilical cord sampling, computed tomography (CT), endoscopic ultrasound (EUS), nipple discharge exam, nonstress tests (NST), pelvic floor strength tests, and post-void residual measurement (PVR). Owing to these properties, women’s health diagnostic testing solutions find extensive applications in diagnostic and imaging centers, hospitals, home care, and clinics across the globe.

Women's Health Diagnostics Market Trends and Drivers:

The market is primarily driven by the increasing prevalence of infectious diseases, such as urinary tract infections (UTIs), human immunodeficiency virus (HIV), breast cancer, and tuberculosis, which impact the well-being of women. In addition, the growing health consciousness and rising awareness regarding the advantages of early diagnosis are contributing to the market growth.

Moreover, several research studies concluded that women are more likely to experience psychiatric disorders, including anxiety, and depression, during hormonal changes, which represents another major growth-inducing factor. Besides this, the introduction of hybrid imaging instruments with enhanced accuracy to diagnose cancer and the development of a genomics-based diagnostic test for early identification of women susceptible to pregnancy complications and preterm birth are propelling the market growth.

Along with this, governments of various countries are taking the initiative to provide free health checkups to pregnant women and distribute free self-testing kits, which are providing a thrust to the market growth. Furthermore, the rising infertility rate, aging women population, and increasing consumption of alcohol and drugs are some of the other factors creating a positive market outlook across the globe.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/womens-health-diagnostics-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Women's Health Diagnostics Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

The report has segmented the market on the basis of region, type, application and end user.

Breakup by Type:

• Diagnostic Devices
  • Biopsy Device
  • Imaging and Monitoring Devices
  • Accessories and Consumables
• Diagnostic Tests
  • Breast Cancer Testing
  • PAP Smear and HPV Test
  • Pregnancy Testing and Ovulation Testing
  • Others

Breakup by Application:

• Breast Cancer
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Sexually Transmitted Disease Testing
• Others

Breakup by End User:

• Hospital and Diagnostics Centers
• Home Care

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others

• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

 Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/womens-health-diagnostics-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Article source: https://article-realm.com/article/Finance/34752-Womens-Health-Diagnostics-Market-Size-2022-Growth-Outlook-Industry-Report-2027.html